Clinical utility of diagnostic biomarkers in malignant pleural mesothelioma: a systematic review and meta-analysis
出版年份 2021 全文链接
标题
Clinical utility of diagnostic biomarkers in malignant pleural mesothelioma: a systematic review and meta-analysis
作者
关键词
-
出版物
European Respiratory Review
Volume 30, Issue 162, Pages 210057
出版商
European Respiratory Society (ERS)
发表日期
2021-11-18
DOI
10.1183/16000617.0057-2021
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial
- (2021) Paul Baas et al. LANCET
- ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma
- (2020) Arnaud Scherpereel et al. EUROPEAN RESPIRATORY JOURNAL
- MicroRNA Signatures in Malignant Pleural Mesothelioma Effusions
- (2019) Kimberly A. Birnie et al. DISEASE MARKERS
- Mesothelin, Calretinin, and Megakaryocyte Potentiating Factor as Biomarkers of Malignant Pleural Mesothelioma
- (2019) Carmina Jiménez-Ramírez et al. LUNG
- Liquid Biopsy in Malignant Pleural Mesothelioma: State of the Art, Pitfalls, and Perspectives
- (2019) Ilaria Cavallari et al. Frontiers in Oncology
- Evolution of clinical and environmental health applications of exhaled breath research: Review of methods and instrumentation for gas-phase, condensate, and aerosols
- (2018) M. Ariel Geer Wallace et al. ANALYTICA CHIMICA ACTA
- Clinical evaluation of circulating miR-548a-3p and -20a expression in malignant pleural mesothelioma patients
- (2018) Marwa Matboli et al. Biomarkers in Medicine
- Macrophage sensing of single-walled carbon nanotubes via Toll-like receptors
- (2018) Sourav P. Mukherjee et al. Scientific Reports
- Biomarkers in mesothelioma
- (2017) David T Arnold et al. ANNALS OF CLINICAL BIOCHEMISTRY
- Pleural effusion biomarkers and computed tomography findings in diagnosing malignant pleural mesothelioma: A retrospective study in a single center
- (2017) Takehiro Otoshi et al. PLoS One
- Young investigator challenge: MicroRNA-21/MicroRNA-126 profiling as a novel tool for the diagnosis of malignant mesothelioma in pleural effusion cytology
- (2016) Rocco Cappellesso et al. CANCER CYTOPATHOLOGY
- HMGB1 and Its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma Patients
- (2016) A. Napolitano et al. CLINICAL CANCER RESEARCH
- Evaluation of New Biomarkers in the Prediction of Malignant Mesothelioma in Subjects with Environmental Asbestos Exposure
- (2016) Melike Demir et al. LUNG
- Combined circulating epigenetic markers to improve mesothelin performance in the diagnosis of malignant mesothelioma
- (2015) Lory Santarelli et al. LUNG CANCER
- Exhaled Breath Condensate: Technical and Diagnostic Aspects
- (2015) Efstathia M. Konstantinidi et al. TheScientificWorldJOURNAL
- Exhaled Breath Condensate: Technical and Diagnostic Aspects
- (2015) Efstathia M. Konstantinidi et al. Scientific World Journal
- Exact and Asymptotic Weighted Logrank Tests for Interval Censored Data: TheintervalRPackage
- (2015) Michael P. Fay et al. Journal of Statistical Software
- CEA, AFP, CA125, CA153 and CA199 in Malignant Pleural Effusions Predict the Cause
- (2014) Xin-Feng Wang et al. Asian Pacific Journal of Cancer Prevention
- Strengths, Weaknesses, and Opportunities of Diagnostic Breathomics in Pleural Mesothelioma--A Hypothesis
- (2014) K. Lamote et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Pleural Fluid Mesothelin as an Adjunct to the Diagnosis of Pleural Malignant Mesothelioma
- (2014) Jenette Creaney et al. DISEASE MARKERS
- Genetic Variation within the Mx Gene of Commercially Selected Chicken Lines Reveals Multiple Haplotypes, Recombination and a Protein under Selection Pressure
- (2014) Janet E. Fulton et al. PLoS One
- Combination of MiR-103a-3p and Mesothelin Improves the Biomarker Performance of Malignant Mesothelioma Diagnosis
- (2014) Daniel G. Weber et al. PLoS One
- Protein Profiling of Pleural Effusions to Identify Malignant Pleural Mesothelioma Using SELDI-TOF MS
- (2014) Joost P.J.J. Hegmans et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma
- (2014) Jenette Creaney et al. THORAX
- Comparison of the Diagnostic Accuracy of theMSLNGene Products, Mesothelin and Megakaryocyte Potentiating Factor, as Biomarkers for Mesothelioma in Pleural Effusions and Serum
- (2013) Jenette Creaney et al. DISEASE MARKERS
- Combination of Mesothelin and CEA Significantly Improves the Differentiation between Malignant Pleural Mesothelioma, Benign Asbestos Disease, and Lung Cancer
- (2013) Thomas Muley et al. Journal of Thoracic Oncology
- Serum Biomarkers in Patients with Mesothelioma and Pleural Plaques and Healthy Subjects Exposed to Naturally Occurring Asbestos
- (2013) Mehmet Bayram et al. LUNG
- Diagnostic value of mesothelin in pleural fluids: comparison with CYFRA 21-1 and CEA
- (2013) Rosa Filiberti et al. MEDICAL ONCOLOGY
- Proteome Screening of Pleural Effusions Identifies Galectin 1 as a Diagnostic Biomarker and Highlights Several Prognostic Biomarkers for Malignant Mesothelioma
- (2013) Filip Mundt et al. MOLECULAR & CELLULAR PROTEOMICS
- Hyaluronan and N-ERC/Mesothelin as Key Biomarkers in a Specific Two-Step Model to Predict Pleural Malignant Mesothelioma
- (2013) Filip Mundt et al. PLoS One
- Pleural fluid cell-free DNA integrity index to identify cytologically negative malignant pleural effusions including mesotheliomas
- (2012) Krishna B Sriram et al. BMC CANCER
- Evaluation of Soluble Mesothelin-related Peptide as a Diagnostic Marker of Malignant Pleural Mesothelioma Effusions: Its Contribution to Cytology
- (2012) Pier Aldo Canessa et al. CANCER INVESTIGATION
- Clinical significance of circulating miR-126 quantification in malignant mesothelioma patients
- (2012) Marco Tomasetti et al. CLINICAL BIOCHEMISTRY
- Serum concentration of integrin-linked kinase in malignant pleural mesothelioma and after asbestos exposure†
- (2012) Stefan B. Watzka et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- A prospective trial evaluating the role of mesothelin in undiagnosed pleural effusions
- (2012) C. E. Hooper et al. EUROPEAN RESPIRATORY JOURNAL
- Serum Mesothelin for Diagnosing Malignant Pleural Mesothelioma: An Individual Patient Data Meta-Analysis
- (2012) Kevin Hollevoet et al. JOURNAL OF CLINICAL ONCOLOGY
- CCL2, Galectin-3, and SMRP Combination Improves the Diagnosis of Mesothelioma in Pleural Effusions
- (2012) Christophe Blanquart et al. Journal of Thoracic Oncology
- Fibulin-3 as a Blood and Effusion Biomarker for Pleural Mesothelioma
- (2012) Harvey I. Pass et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early Detection of Malignant Pleural Mesothelioma in Asbestos-Exposed Individuals with a Noninvasive Proteomics-Based Surveillance Tool
- (2012) Rachel M. Ostroff et al. PLoS One
- Is Serum Thioredoxin-1 a Useful Clinical Marker for Malignant Pleural Mesothelioma?
- (2011) Risa Maeda et al. ANTIOXIDANTS & REDOX SIGNALING
- Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008
- (2011) Vanya Delgermaa et al. BULLETIN OF THE WORLD HEALTH ORGANIZATION
- The Effect of Clinical Covariates on the Diagnostic and Prognostic Value of Soluble Mesothelin and Megakaryocyte Potentiating Factor
- (2011) Kevin Hollevoet et al. CHEST
- Detection of integrin-linked kinase in the serum of patients with malignant pleural mesothelioma
- (2011) Stefan B. Watzka et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Combined Serum Mesothelin and Plasma Osteopontin Measurements in Malignant Pleural Mesothelioma
- (2011) Alfonso Cristaudo et al. Journal of Thoracic Oncology
- Plasma versus serum levels of osteopontin and mesothelin in patients with malignant mesothelioma—Which is best?
- (2011) Jenette Creaney et al. LUNG CANCER
- Association of MiR-126 with Soluble Mesothelin-Related Peptides, a Marker for Malignant Mesothelioma
- (2011) Lory Santarelli et al. PLoS One
- Diagnostic Performance of Soluble Mesothelin and Megakaryocyte Potentiating Factor in Mesothelioma
- (2010) Kevin Hollevoet et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Soluble mesothelin related peptides (SMRP) and osteopontin as protein biomarkers for malignant mesothelioma: analytical validation of ELISA based assays and characterization at mRNA and protein levels
- (2010) Alex J. Rai et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Diagnostic and Prognostic Value of Soluble Mesothelin-Related Proteins in Patients with Malignant Pleural Mesothelioma in Comparison with Benign Asbestosis and Lung Cancer
- (2010) Joachim Schneider et al. Journal of Thoracic Oncology
- Comparison of Osteopontin, Megakaryocyte Potentiating Factor, and Mesothelin Proteins as Markers in the Serum of Patients with Malignant Mesothelioma
- (2010) Jenette Creaney et al. Journal of Thoracic Oncology
- Sensitivity of Urinary Mesothelin in Patients with Malignant Mesothelioma
- (2010) Jenette Creaney et al. Journal of Thoracic Oncology
- Soluble mesothelin-related protein in pleural effusion from patients with malignant pleural mesothelioma
- (2010) NOBUKAZU FUJIMOTO et al. Experimental and Therapeutic Medicine
- Clinical Impact and Reliability of Pleural Fluid Mesothelin in Undiagnosed Pleural Effusions
- (2009) Helen E. Davies et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Serum Levels of Soluble Mesothelin-Related Peptides in Malignant and Nonmalignant Asbestos-Related Pleural Disease: Relation with Past Asbestos Exposure
- (2009) J. A. Rodriguez Portal et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Pleural fluid mesothelin for the differential diagnosis of exudative pleural effusions
- (2009) Carmen Alemán et al. MEDICINA CLINICA
- Exhaled breath condensate biomarkers in asbestos-related lung disorders
- (2009) Sharron Chow et al. RESPIRATORY MEDICINE
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Profiling Tumor-Associated Markers for Early Detection of Malignant Mesothelioma: An Epidemiologic Study
- (2008) M. Amati et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Soluble Mesothelin-Related Peptide Level Elevation in Mesothelioma Serum and Pleural Effusions
- (2007) Harvey I. Pass et al. ANNALS OF THORACIC SURGERY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search